William G Morice 2nd
Overview
Explore the profile of William G Morice 2nd including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
214
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vachon C, Norman A, Prasad K, Jensen D, Schaeferle G, Vierling K, et al.
Mayo Clin Proc Innov Qual Outcomes
. 2022 Oct;
6(6):605-617.
PMID: 36277251
Objective: To estimate rates and identify factors associated with asymptomatic COVID-19 in the population of Olmsted County during the prevaccination era. Patients And Methods: We screened first responders (n=191) and...
2.
Vardhana S, Baldo L, Morice 2nd W, Wherry E
Sci Immunol
. 2022 Mar;
7(71):eabo1303.
PMID: 35324269
Durable T cell responses to SARS-CoV-2 antigens after infection or vaccination improve immune-mediated viral clearance. To date, population-based surveys of COVID-19 adaptive immunity have focused on testing for IgG antibodies...
3.
OHoro J, Cerhan J, Cahn E, Bauer P, Temesgen Z, Ebbert J, et al.
Mayo Clin Proc
. 2021 Mar;
96(3):601-618.
PMID: 33673913
Objective: To report the Mayo Clinic experience with coronavirus disease 2019 (COVID-19) related to patient outcomes. Methods: We conducted a retrospective chart review of patients with COVID-19 diagnosed between March...
4.
Agarwal V, Venkatakrishnan A, Puranik A, Kirkup C, Lopez-Marquez A, Challener D, et al.
Cell Death Discov
. 2020 Dec;
6(1):138.
PMID: 33298894
Longitudinal characterization of SARS-CoV-2 PCR testing from COVID-19 patient's nasopharynx and its juxtaposition with blood-based IgG-seroconversion diagnostic assays is critical to understanding SARS-CoV-2 infection durations. Here, we retrospectively analyze 851...
5.
Pawlowski C, Wagner T, Puranik A, Murugadoss K, Loscalzo L, Venkatakrishnan A, et al.
Elife
. 2020 Aug;
9.
PMID: 32804081
Temporal inference from laboratory testing results and triangulation with clinical outcomes extracted from unstructured electronic health record (EHR) provider notes is integral to advancing precision medicine. Here, we studied 246...
6.
Wagner T, Shweta F, Murugadoss K, Awasthi S, Venkatakrishnan A, Bade S, et al.
Elife
. 2020 Jul;
9.
PMID: 32633720
Understanding temporal dynamics of COVID-19 symptoms could provide fine-grained resolution to guide clinical decision-making. Here, we use deep neural networks over an institution-wide platform for the augmented curation of clinical...
7.
Agarwal V, Venkatakrishnan A, Puranik A, Kirkup C, Lopez-Marquez A, Challener D, et al.
medRxiv
. 2020 Jun;
PMID: 32577666
Analysis of 851 COVID-19 patients with a SARS-CoV-2-positive PCR at follow-up shows 99 patients remained SARS-CoV-2-positive after four weeks from initial diagnosis. Surprisingly, a majority of these long-term viral RNA...
8.
Foucar K, Hsi E, Wang S, Rogers H, Hasserjian R, Bagg A, et al.
Int J Lab Hematol
. 2020 Apr;
42(4):418-422.
PMID: 32297416
Enumeration of blasts and promonocytes is essential for World Health Organization (WHO) classification of myelomonocytic neoplasms. The accuracy of distinguishing blasts, promonocytes and monocytes, including normal vs abnormal monocytes, remains...
9.
Fang H, Kapoor P, Gonsalves W, Frederick L, Viswanatha D, Howard M, et al.
Am J Clin Pathol
. 2018 Jun;
150(2):168-176.
PMID: 29868855
Objectives: Lymphoplasmacytic lymphoma (LPL) remains a poorly defined entity, even with the discovery of MYD88L265P mutations and association with Waldenström macroglobulinemia (WM). Among bone marrow (BM)-based, low-grade B-cell lymphoma with...